Please indicate your profession: *

Endocrinologist

Cardiologist

Primary care physician

Physician assistant

Nurse

Nurse practitioner

Other (please specify)

Please specify here

In your practice, how many of your patients achieve their LDL-C goal? *

<20%

21-40%

41-60%

61-80%

>80%

In your practice, how often do you directly measure LDL-C vs. calculating LDL-C *

<20%

21-40%

41-60%

61-80%

>80%

Please rate your level of agreement regarding dyslipidemia: *

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
More aggressive management of lipids is needed to achieve lower LDL-C levels.	More aggressive management of lipids is needed to achieve lower LDL-C levels. - Strongly Agree	More aggressive management of lipids is needed to achieve lower LDL-C levels. - Agree	More aggressive management of lipids is needed to achieve lower LDL-C levels. - Neutral	More aggressive management of lipids is needed to achieve lower LDL-C levels. - Disagree	More aggressive management of lipids is needed to achieve lower LDL-C levels. - Strongly Disagree
It is possible for patients to achieve therapeutic goals for LDL-C with statins.	It is possible for patients to achieve therapeutic goals for LDL-C with statins. - Strongly Agree	It is possible for patients to achieve therapeutic goals for LDL-C with statins. - Agree	It is possible for patients to achieve therapeutic goals for LDL-C with statins. - Neutral	It is possible for patients to achieve therapeutic goals for LDL-C with statins. - Disagree	It is possible for patients to achieve therapeutic goals for LDL-C with statins. - Strongly Disagree

Regarding the management of dyslipidemia, please indicate your level of competency (ie, ability to apply knowledge to practice) to: *

	Very high	High	Medium	Low	Very low
Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient.	Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. - Very high	Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. - High	Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. - Medium	Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. - Low	Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. - Very low
Implement treatment strategies tailored for special populations of patients at high CV risk.	Implement treatment strategies tailored for special populations of patients at high CV risk. - Very high	Implement treatment strategies tailored for special populations of patients at high CV risk. - High	Implement treatment strategies tailored for special populations of patients at high CV risk. - Medium	Implement treatment strategies tailored for special populations of patients at high CV risk. - Low	Implement treatment strategies tailored for special populations of patients at high CV risk. - Very low
Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles.	Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. - Very high	Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. - High	Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. - Medium	Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. - Low	Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. - Very low
Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions.	Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. - Very high	Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. - High	Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. - Medium	Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. - Low	Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. - Very low

Leave this field blank